Predictors of poor outcome in patients with autoimmune hepatitis: A population-based study

被引:87
作者
Ngu, Jing Hieng [1 ,2 ]
Gearry, Richard Blair [1 ,2 ]
Frampton, Chris Miles [2 ]
Stedman, Catherine A. M. [1 ,2 ]
机构
[1] Christchurch Hosp, Dept Gastroenterol, Canterbury, New Zealand
[2] Univ Otago, Canterbury, New Zealand
关键词
LIVER-DISEASES; CIRRHOSIS; EXPERIENCE; MANAGEMENT; PREGNANCY; REMISSION; PROGNOSIS; CHILDREN; GENDER; WOMEN;
D O I
10.1002/hep.26290
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Autoimmune hepatitis (AIH) can lead to cirrhosis, hepatic failure, and death. We aimed to identify predictors of advanced liver fibrosis at presentation, predictors of incomplete response to initial immunosuppression, and predictors of poor liver-related outcomes in the population-based AIH cohort from Canterbury, New Zealand. Cases diagnosed after 1980 that fulfilled standard diagnostic criteria were included. Cases were censored at death or liver transplantation and had a median follow-up of 9 years. Analyses were performed with Cox proportional hazards regression and logistic binary regression. The times to event outcomes were summarized using Kaplan-Meier curves. A total of 133 AIH patients were included. Predictors for advanced liver fibrosis at diagnosis were age at presentation of 20 years or >60 years (P = 0.02), serum albumin <36 g/L (P < 0.01), platelet <150 U/L (P < 0.01), and International Normalized Ratio (INR) >1.2 (P < 0.01). The only independent predictor for incomplete normalization of alanine aminotransferase (ALT) at 6 months was age at presentation 20 years. Independent predictors of poor liver-related outcomes were incomplete normalization of ALT at 6 months (P < 0.01), serum albumin <36 g/L (P < 0.01), and age at presentation of 20 years or >60 years (P = 0.01). Kaplan-Meier estimates showed that 10-year adverse liver event-free survival was 80% for age at presentation 20 years and >60 years, and 93% and 100% for age at presentation between 21-40 years and 41-60 years, respectively. Conclusion: Incomplete normalization of ALT at 6 months, low serum albumin concentration at diagnosis, and age at presentation of 20 years or >60 years were significant independent predictors of liver-related death or requirement for liver transplantation. Histological cirrhosis at diagnosis was not associated with poor prognosis and did not influence the response to initial immunosuppressive treatment. (HEPATOLOGY 2013;57:2399-2406)
引用
收藏
页码:2399 / 2406
页数:8
相关论文
共 32 条
[1]   Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis [J].
Al-Chalabi, Thawab ;
Underhill, James A. ;
Portmann, Bernard C. ;
McFarlane, Ian G. ;
Heneghan, Michael A. .
JOURNAL OF HEPATOLOGY, 2008, 48 (01) :140-147
[2]   Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AM followed at a tertiary referral centre [J].
Al-Chalabi, Thawab ;
Boccato, Sylvia ;
Portmann, Bernard C. ;
McFarlane, Ian G. ;
Heneghan, Michael A. .
JOURNAL OF HEPATOLOGY, 2006, 45 (04) :575-583
[3]   Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome [J].
Al-Chalabi, Thawab ;
Underhill, James A. ;
Portmann, Bernard C. ;
McFarlane, Ian G. ;
Heneghan, Michael A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (12) :1389-1395
[4]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[5]   Sex hormones and the immune response in humans [J].
Bouman, A ;
Heineman, MJ ;
Faas, MM .
HUMAN REPRODUCTION UPDATE, 2005, 11 (04) :411-423
[6]  
Buchel E, 2002, AM J GASTROENTEROL, V97, P3160
[7]   Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly [J].
Czaja, AJ ;
Carpenter, HA .
HEPATOLOGY, 2006, 43 (03) :532-538
[8]   Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome [J].
Feld, JJ ;
Dinh, H ;
Arenovich, T ;
Marcus, VA ;
Wanless, IR ;
Heathcote, EJ .
HEPATOLOGY, 2005, 42 (01) :53-62
[9]   Gender as risk factor for autoimmune diseases [J].
Gleicher, Norbert ;
Barad, David H. .
JOURNAL OF AUTOIMMUNITY, 2007, 28 (01) :1-6
[10]   Autoimmune hepatitis in childhood: A 20-year experience [J].
Gregorio, GV ;
Portmann, B ;
Reid, F ;
Donaldson, PT ;
Doherty, DG ;
McCartney, M ;
Mowat, AP ;
Vergani, D ;
MieliVergani, G .
HEPATOLOGY, 1997, 25 (03) :541-547